Palisade Bio, Inc. (PALI)
NASDAQ: PALI · Real-Time Price · USD
1.750
-0.050 (-2.78%)
Dec 20, 2024, 4:00 PM EST - Market closed
Palisade Bio Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
Dec '24 Dec 20, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Market Capitalization | 2 | 5 | 8 | 18 | - | - | |
Market Cap Growth | -21.43% | -31.77% | -54.57% | - | - | - | |
Enterprise Value | -5 | -9 | -5 | 4 | - | - | |
Last Close Price | 1.75 | 8.85 | 78.00 | 975.00 | - | - | |
PS Ratio | - | 21.88 | - | - | - | - | |
PB Ratio | 0.32 | 0.48 | 0.64 | 2.40 | - | - | |
P/TBV Ratio | 0.64 | 0.48 | 0.64 | 2.40 | - | - | |
Debt / Equity Ratio | 0.05 | 0.03 | 0.03 | 0.03 | -0.20 | 0.44 | |
Asset Turnover | - | 0.02 | - | - | - | - | |
Quick Ratio | 3.04 | 4.86 | 4.59 | 4.26 | 0.10 | 1.32 | |
Current Ratio | 3.31 | 5.15 | 4.89 | 4.61 | 0.11 | 1.37 | |
Return on Equity (ROE) | -135.96% | -103.40% | -143.72% | -20012.03% | - | - | |
Return on Assets (ROA) | -68.20% | -53.85% | -67.69% | -94.46% | -161.72% | -270.51% | |
Return on Capital (ROIC) | -83.58% | -65.36% | -93.60% | -777.90% | - | - | |
Earnings Yield | -604.52% | -224.87% | -177.89% | -150.84% | - | - | |
FCF Yield | -539.75% | -203.61% | -166.79% | -83.72% | - | - | |
Buyback Yield / Dilution | -210.81% | -677.03% | -370.85% | - | - | -99.30% | |
Total Shareholder Return | -210.81% | -677.03% | -370.85% | - | - | -99.30% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.